Difference between revisions of "Paroxetine-moclobemide"
From Psychiatrienet
(Created page with '{{Drugswitch | from = paroxetine | to = moclobemide | stop = Depending on the condition of the patient, there are two scenarios possible: # Gradually reduce dosage of paroxeti...') |
|||
| Line 10: | Line 10: | ||
* Then the administration of moclobemide can be started in normal dosage of 300 mg/day (2 times a day 150 mg). | * Then the administration of moclobemide can be started in normal dosage of 300 mg/day (2 times a day 150 mg). | ||
| info = | | info = | ||
| − | |||
* Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.}} | * Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.}} | ||
Revision as of 11:05, 15 July 2009
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Switch medication from paroxetine to moclobemide.[1] [2]
Stop paroxetine Depending on the condition of the patient, there are two scenarios possible:
- Gradually reduce dosage of paroxetine to a maximum of 20 mg/day, and then stop administration abruptly.
- Phase out paroxetine from 20 mg/day, to 10 mg/day for one week, and then stop administration abruptly.
Start moclobemide- Both scenarios are followed by a wash-out period of one week.
- Then the administration of moclobemide can be started in normal dosage of 300 mg/day (2 times a day 150 mg).
More information- Occurrence of serotonin syndrome is reported when a wash-out period (of one week) is not considered.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
